SHIELD 4 Phase 3 Clinical Trial With Orally Administered CCR9 Inhibitor Vercirnon in Crohn's Disease

Keshav S., Schall T., Bekker P.

Type

Conference paper

Publication Date

10/2014

Volume

109

Pages

S498 - S498

Permalink